Pharma prepares for Brexit as Tories win election majorityBoris Johnson’s Conservatives have won the UK’s general election with a large majority, leaving the industry preparing for Share XPharma prepares for Brexit as Tories win election majorityhttps://pharmaphorum.com/news/pharma-prepares-for-brexit-as-tories-win-election-majority/
UK’s NHS to fund Shionogi’s Mulpleo after backing from NICE and SMCShionogi’s Mulpleo for severely low levels of blood platelets caused by liver disease is to be made available Share XUK’s NHS to fund Shionogi’s Mulpleo after backing from NICE and SMChttps://pharmaphorum.com/news/uks-nhs-to-fund-shionogis-mulpleo-after-backing-from-nice-and-smc/
Mylan and Biocon launch Herceptin biosimilar in USMylan and Biocon have launched their Herceptin biosimilar Ogivri in the US, the second challenger to Roche’s breast Share XMylan and Biocon launch Herceptin biosimilar in UShttps://pharmaphorum.com/news/mylan-and-biocon-launch-herceptin-biosimilar-in-us/
ICER says ‘marginal’ benefits for AbbVie’s new RA drugAbbVie’s Rinvoq rheumatoid arthritis drug is an important part of the company’s strategy to replace lost sales as Share XICER says ‘marginal’ benefits for AbbVie’s new RA drughttps://pharmaphorum.com/news/icer-says-marginal-benefits-for-abbvies-new-ra-drug/
Drugs firms make massive discounts to get reimbursement in ChinaRoche and Novartis are among the pharmaceuticals companies who have agreed to cut prices of some of their Share XDrugs firms make massive discounts to get reimbursement in Chinahttps://pharmaphorum.com/news/drugs-firms-make-massive-discounts-to-get-reimbursement-in-china/
Trump’s reps ‘pushed hard’ for UK drug price reforms, leaked documents showRepresentatives of the Trump administration have “pushed hard” for pro-US drug pricing reforms in free trade negotiations with Share XTrump’s reps ‘pushed hard’ for UK drug price reforms, leaked documents showhttps://pharmaphorum.com/news/trump-administration-pushed-hard-for/
UK should pay $25 million for ‘Netflix’ antibiotic subscriptionAn expert has said the UK must pay upwards of $25 million per year to drug companies developing Share XUK should pay $25 million for ‘Netflix’ antibiotic subscriptionhttps://pharmaphorum.com/news/uk-should-pay-at-least-25-million-for-netflix-antibiotic-subscription-says-expert/
Labour peer says he opposes Corbyn-style state-funded drugs firmA Labour peer has spoken out against the idea of a nationalised drugs industry, saying that proposals for Share XLabour peer says he opposes Corbyn-style state-funded drugs firmhttps://pharmaphorum.com/news/labour-peer-corbyn-state-funded-drugs/
NICE backs NHS funding for two cannabis-based drugs for first timeNICE has recommended two of GW Pharma’s cannabis-based medicines, the first time that medicines derived from the plant Share XNICE backs NHS funding for two cannabis-based drugs for first timehttps://pharmaphorum.com/news/nice-includes-bayer-gws-cannabis-based-sativex-in-ms-guideline-for-first-time/
